Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study.

Ther Adv Gastroenterol · 2023 · PMC10026122 · PMID 36950251

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

During tofacitinib treatment, the least-squares means of the partial Mayo score significantly decreased from week 16 and showed a decreasing trend thereafter ( Figure 1(c) ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.